957 NKTR-255+cetuximab in patients with solid tumors: interim safety and efficacy results from the phase 1b dose-escalation study

• Manish Patel,
• Amita Patnaik,
• Ammar Sukari,
• Minal Barve,
• Mary Tagliaferri,
• Neha Dixit,
• Mehmet Altan,
• Christie Fanton,
• Xiaoli Wang,
• Sunil Sharma,
• Mario Marcondes,
• Sue Currie,
• Zachary Lee,
• Wildaliz Nieves,
• Haijun Ma,
• Lara Dunn,
• Patrick Cobb,
• Ari Rosenberg,
• Johnathan Zalevsky,
• Assuntina Sacco

Affiliations

Manish Patel

General Medicine, University Hospital Wishaw, Wishaw, UK

Amita Patnaik

3South Texas Accelerated Research Therape, San Antonio, TX, USA

Ammar Sukari

Aff238 grid.254444.70000000114567807Karmanos Cancer Institute Detroit MI USA

Minal Barve

Aff462 grid.416487.80000000404554449Mary Crowley Cancer Research Centers, Texas Oncology, P.A Dallas TX USA

Mary Tagliaferri

7Nektar Therapeutics, San Francisco, CA, USA

Neha Dixit

Aff2 grid.429615.dNodality 170 Harbor Way 94080 South San Francisco CA USA

Mehmet Altan

Aff9 0000 0001 2291 4776grid.240145.6Thoracic Head and Neck Medical OncologyThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX USA

Christie Fanton

7Nektar Therapeutics, San Francisco, CA, USA

Xiaoli Wang

School of Public Health, Peking University Health Science Centre, Beijing, China

Sunil Sharma

7HonorHealth Research Institute, Scottsdale, AZ, USA

Mario Marcondes

7Nektar Therapeutics, San Francisco, CA, USA

Sue Currie

12Nektar Therapeutics, San Francisco, CA, USA

Zachary Lee

11Nektar Therapeutics, San Francisco, CA, USA

Wildaliz Nieves

11Nektar Therapeutics, San Francisco, CA, USA

Haijun Ma

11Nektar Therapeutics, San Francisco, CA, USA

Lara Dunn

5Memorial Sloan Kettering Cancer Center, New York, NY, USA

Patrick Cobb

5St. Vincent Frontier Cancer Center, Billings, MT, USA

Ari Rosenberg

6University of Chicago, Chicago, IL, USA

Johnathan Zalevsky

10Nektar Therapeutics, San Francisco, CA, USA

Assuntina Sacco

12University California San Diego, La Jolla, CA, USA